BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36880904)

  • 1. Implementation of a hospital-based intervention for MOUD initiation and referral to a Bridge Clinic for opioid use disorder.
    Audet CM; Pettapiece-Phillips M; Kast K; White KD; Perkins JM; Marcovitz D
    J Subst Use Addict Treat; 2023 Mar; 146():208961. PubMed ID: 36880904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Co-Located Bridging Recovery Initiative on Hospital Length of Stay Among Patients With Opioid Use Disorder: The BRIDGE Randomized Clinical Trial.
    Marcovitz D; Dear ML; Donald R; Edwards DA; Kast KA; Le TDV; Shah MV; Ferrell J; Gatto C; Hennessy C; Buie R; Rice TW; Sullivan W; White KD; Van Winkle G; Wolf R; Lindsell CJ;
    JAMA Netw Open; 2024 Feb; 7(2):e2356430. PubMed ID: 38411964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency department interventions for opioid use disorder: A synthesis of emerging models.
    Thomas CP; Stewart MT; Tschampl C; Sennaar K; Schwartz D; Dey J
    J Subst Abuse Treat; 2022 Oct; 141():108837. PubMed ID: 35841743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.
    Martin A; Butler K; Chavez T; Herring A; Wakeman S; Hayes BD; Raja A
    West J Emerg Med; 2020 Nov; 21(6):257-263. PubMed ID: 33207174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
    Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
    J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE): study protocol for a randomized controlled trial of a bridge clinic compared with usual care for patients with opioid use disorder.
    Marcovitz DE; White KD; Sullivan W; Limper HM; Dear ML; Buie R; Edwards DA; Chastain C; Kast KA; Lindsell CJ;
    Trials; 2021 Oct; 22(1):757. PubMed ID: 34717736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals.
    Patel E; Solomon K; Saleem H; Saloner B; Pugh T; Hulsey E; Leontsini E
    J Subst Abuse Treat; 2022 May; 136():108658. PubMed ID: 34774397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.
    O'Grady MA; Elkington KS; Robson G; Achebe IY; Williams AR; Cohall AT; Cohall R; Christofferson M; Garcia A; Ramsey KS; Lincourt P; Tross S
    Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):12. PubMed ID: 38287329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridge clinic buprenorphine program decreases emergency department visits.
    Sullivan RW; Szczesniak LM; Wojcik SM
    J Subst Abuse Treat; 2021 Nov; 130():108410. PubMed ID: 34118702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES.
    Huo S; Heil J; Salzman MS; Carroll G; Haroz R
    J Emerg Med; 2023 Mar; 64(3):391-396. PubMed ID: 37019500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial.
    Whiteside LK; Huynh L; Morse S; Hall J; Meurer W; Banta-Green CJ; Scheuer H; Cunningham R; McGovern M; Zatzick DF
    J Subst Abuse Treat; 2022 May; 136():108666. PubMed ID: 34952745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing access to quality care for pregnant and postpartum people with opioid use disorder: Coordination of services, provider awareness and training, extended postpartum coverage, and perinatal quality collaboratives.
    Ellick KL; Kroelinger CD; Chang K; McGown M; McReynolds M; Velonis AJ; Bronson E; Riehle-Colarusso T; Pliska E; Akbarali S; Mueller T; Dronamraju R; Cox S; Barfield WD
    J Subst Use Addict Treat; 2024 Jan; 156():209208. PubMed ID: 37939904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention.
    Smith A; Hansen J; Colvard M
    J Subst Abuse Treat; 2021 Nov; 130():108440. PubMed ID: 34118708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of an emergency department peer navigator (EDPN) program in improving clinical outcomes and healthcare utilization in an urban setting.
    Santos C; Ramdin C; Becceril J; Al Kik B; Jefri M; Nelson L
    Am J Emerg Med; 2023 Jun; 68():10-16. PubMed ID: 36905880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder.
    Hawk K; McCormack R; Edelman EJ; Coupet E; Toledo N; Gauthier P; Rotrosen J; Chawarski M; Martel S; Owens P; Pantalon MV; O'Connor P; Whiteside LK; Cowan E; Richardson LD; Lyons MS; Rothman R; Marsch L; Fiellin DA; D'Onofrio G
    JAMA Netw Open; 2022 Jan; 5(1):e2144955. PubMed ID: 35076700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment.
    McNeely J; Troxel AB; Kunins HV; Shelley D; Lee JD; Walley A; Weinstein ZM; Billings J; Davis NJ; Marcello RK; Schackman BR; Barron C; Bergmann L
    Addict Sci Clin Pract; 2019 Feb; 14(1):5. PubMed ID: 30777122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications for opioid use disorder in rural primary care practices: Patient and provider experiences.
    Bridges NC; Taber R; Foulds AL; Bear TM; Cloutier RM; McDonough BL; Gordon AJ; Cochran GT; Donohue JM; Adair D; DiDomenico E; Pringle JL; Gellad WF; Kelley D; Cole ES
    J Subst Use Addict Treat; 2023 Nov; 154():209133. PubMed ID: 37543217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
    Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
    JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
    Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
    Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.